194 related articles for article (PubMed ID: 33590974)
1. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
[TBL] [Abstract][Full Text] [Related]
2. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery.
Tan S; Xu J; Wang J; Zhang Z; Li S; Yan M; Tang M; Liu H; Zhuang Q; Xi Q; Meng Q; Jiang Y; Wu G
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):891-902. PubMed ID: 36880286
[TBL] [Abstract][Full Text] [Related]
5. Triceps skinfold-albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study.
Yin L; Cui J; Lin X; Li L; Li N; Fan Y; Zhang L; Liu J; Chong F; Lu Z; Wang C; Liang T; Liu X; Deng L; Yang M; Yu J; Wang X; Cong M; Li Z; Weng M; Yao Q; Jia P; Guo Z; Li W; Song C; Shi H; Xu H
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):517-533. PubMed ID: 36567070
[TBL] [Abstract][Full Text] [Related]
6. Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden.
Hong N; Yoon HJ; Lee YH; Kim HR; Lee BW; Rhee Y; Kang ES; Cha BS; Lee HC
J Clin Endocrinol Metab; 2016 Mar; 101(3):1207-14. PubMed ID: 26765580
[TBL] [Abstract][Full Text] [Related]
7. Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle.
Johns N; Hatakeyama S; Stephens NA; Degen M; Degen S; Frieauff W; Lambert C; Ross JA; Roubenoff R; Glass DJ; Jacobi C; Fearon KC
PLoS One; 2014; 9(1):e83618. PubMed ID: 24404136
[TBL] [Abstract][Full Text] [Related]
8. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
[No Abstract] [Full Text] [Related]
9. Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases-1 in the prognostic evaluation of primary breast cancer patients.
Würtz SØ; Christensen IJ; Schrohl AS; Mouridsen H; Lademann U; Jensen V; Brünner N
Mol Cell Proteomics; 2005 Apr; 4(4):483-91. PubMed ID: 15640527
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients.
Oh WK; Vargas R; Jacobus S; Leitzel K; Regan MM; Hamer P; Pierce K; Brown-Shimer S; Carney W; Ali SM; Kantoff PW; Lipton A
Cancer; 2011 Feb; 117(3):517-25. PubMed ID: 20862742
[TBL] [Abstract][Full Text] [Related]
11. Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
Luvián-Morales J; Delgadillo-González M; Castro-Eguiluz D; Oñate-Ocaña LF; Cetina-Pérez L
Jpn J Clin Oncol; 2024 Apr; 54(4):416-423. PubMed ID: 38146122
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer).
Poisson J; Martinez-Tapia C; Heitz D; Geiss R; Albrand G; Falandry C; Gisselbrecht M; Couderc AL; Boulahssass R; Liuu E; Boudou-Rouquette P; Chah Wakilian A; Gaxatte C; Pamoukdjian F; de Decker L; Antoine V; Cattenoz C; Solem-Laviec H; Guillem O; Medjenah H; Natella PA; Canouï-Poitrine F; Laurent M; Paillaud E
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1477-1488. PubMed ID: 34519440
[TBL] [Abstract][Full Text] [Related]
13. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
14. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients.
Wallengren O; Lundholm K; Bosaeus I
Support Care Cancer; 2013 Jun; 21(6):1569-77. PubMed ID: 23314651
[TBL] [Abstract][Full Text] [Related]
16. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
[TBL] [Abstract][Full Text] [Related]
17. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
[TBL] [Abstract][Full Text] [Related]
18. Cachexia staging score predicts survival in patients with cancer who receive palliative care.
Ueshima J; Maeda K; Shimizu A; Nagano A; Ishida Y; Takeuchi T; Nonogaki T; Matsuyama R; Yamanaka Y; Murotani K; Mori N
Nutrition; 2023 Feb; 106():111880. PubMed ID: 36436335
[TBL] [Abstract][Full Text] [Related]
19. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
[TBL] [Abstract][Full Text] [Related]
20. Hand grip strength-based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer.
Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Gan J; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):382-390. PubMed ID: 36447437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
